Quick Answer
Exousia Bio, Inc. reported Total Assets of $0.00 for the year ending 2025.
- Exousia Bio, Inc. showed a decrease of -100.0% in Total Assets from 2024 to 2025.
- This data is from Exousia Bio, Inc.'s annual report (Form 10-K), filed with the SEC on October 17, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $37.0 thousand | Q3 2023: $26.8 thousand | Q4 2023: $26.7 thousand | Q1 2024: $26.9 thousand | Q3 2024: $28.0 thousand | Q4 2024: $24.9 thousand | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: $0.00 | Q4 2025: $22.05 million.
- Over the full 4 years of available data (2022 to 2025), Exousia Bio, Inc.'s Total Assets has declined by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $27.5 thousand | Fiscal year 2023: $37.0 thousand | Fiscal year 2022: $54.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: